to

Europe CBD Expo

One Western Gateway Royal Victoria Dock,
London, E16 1XL, United Kingdom

Details

EUROPE CBD Expo – First Ever Hybrid Business and Consumer Event Dedicated to CBD Products – is Coming to London in July 2019

Europe CBD Expo will feature more than 80 exhibitors, a CBD Link Educational and Networking Area, with two full days of presentations and panel discussions from experts in the research, development, and distribution of CBD products.

The hybrid business and consumer event will be open to the public on 13th of July, consumers interested in learning more about CBD’s benefits to cannabis and hemp derived products are invited to attend.

‘’Europe CBD Expo is everything the CBD industry needs, a venue with only reputable and credible CBD brands, that also focuses on educating consumers and businesses who sell CBD to ensure everyone can understand CBD and its benefits. We understand that there are many stigmas around the industry and that sourcing quality CBD products is an issue businesses face when trying to bring CBD products to their store. That’s why we will be testing exhibitors’ products, through random selection, using an independent laboratory to ensure our exhibitors legitimacy and full compliancy within the UK legal requirements.

We think the hybrid business/consumer format of the event is sure to appeal to a wide range of attendees and bring some much-needed attention to the CBD options that so many consumers want to learn about. You will leave the Europe CBD Expo with new understanding to help inform your next steps as a consumer, supplier, manufacturer or retailer of CBD products.’’ – Sal Noble producer of Europe CBD Expo and founder and CEO of London CBD Group

Program

09:30 Jul 12
KEYNOTE SPEAKER
Jim McCormick President, Ignite International Ltd.
10:00 Jul 12
Cannabis Regulatory Intelligence Medical Cannabis and CBD Products in the UK – Quality, Responsibility, Transparency.
Blair Gibbs Policy Lead, Centre for Medicinal Cannabis (CMC)
10:30 Jul 12
Cannabis Regulatory Intelligence The European regulatory framework for CBD and appetite amongst European regulators and the banking sector to provide support to the industry
Mark Taylor Compliance and Regulatory Journalist
11:00 Jul 12
Cannabis Regulatory Intelligence Israel Regulatory Standards Vs European Standards
Golan Bitton CEO, Univo Pharmaceuticals
11:30 Jul 12
COFFEE BREAK
12:00 Jul 12
Cannabis Regulatory Intelligence Regulatory and Market Intelligence for the CBD Sector
Tim Phillips Managing Director, CBD Intel
12:30 Jul 12
Panel Discussion European Regulations, Insights & Opportunities – Where are we now? The Future of Cannabis and CBD
Chaired by Karina Lahnakoski VP of Quality & Regulatory, Cannabis Compliance Inc., George McBrid CEO, Hanway Associates, Housam Nasr COO, London Canna Group, Eveline Van Keymeule Counsel, Allen & Overy, Blair Gibbs Policy Lead CMC, Hassan Akhtar
13:15 Jul 12
KEYNOTE SPEAKER
Awaiting Confirmation
13:45 Jul 12
Cannabinoid Development Strategies Investing in Cannabinoids, cultivation, product development, branding and distribution
Patrick Morton Co-Founder, Cannabis Invest UK
14:15 Jul 12
Cannabinoid Development Strategies Making CBD, Cannabinoids and Medicinal Cannabis affordable: How Emerging Markets will disrupt the global supply chain
Oliver Zugel Founder and CEO, Foliumed
14:45 Jul 12
Cannabinoid Development Strategies CBD, Cannabinoids and Medicinal Cannabis Formulation & Product Development Strategies
Dr Monica Vialpando Founder, Vialpando LLC
15:15 Jul 12
Cannabinoid Development Strategies Awaiting Talk Title
Josh Crossney CEO, Cannabis Science Conference
15:45 Jul 12
The Necessity of Cannabis Testing Awaiting Talk Title
Tracy Szerszon President, Perry Johnson Lab Accreditation Inc
16:15 Jul 12
The Necessity of Cannabis Testing Determination of CBD and General Cannabinoid Content in Hemp Oils
Dr Richard Hodgson LC Technical Specialist, Shimadzu
16:45 Jul 12
The Necessity of Cannabis Testing Optimizing Cannabis Testing with Mass Spectrometry
Daniel McMillan Sr. Manager, SCIEX
17:15 Jul 12
Panel Discussion Emerging Markets and International Trends – International Insights, Opportunities and Investment
Chaired by Stephen Murphy CEO, Prohibition Partners, Michael Patterson CEO, US Cannabis Pharmaceutical Research and Development LLC, Golan Bitton CEO, Univo Pharmaceuticals (Israel), Oliver Zugel Founder and CEO, Foliumed (Columbia)
18:00 Jul 12
Drinks Reception Evening Entertainment
Band The What if Generation
10:00 Jul 13
KEYNOTE
Dr. Zeid Mohamedali Chief Medical Officer, Zenabis
10:30 Jul 13
A Guide to CBD, Cannabinoids and Medical Cannabis CBD & Cannabinoids for Everyone
Dr Dani Gordon Doctor, Author, ABIHM, ABIOM
11:00 Jul 13
A Guide to CBD, Cannabinoids and Medical Cannabis Awaiting Talk Title
Prof. Ram Reifen Director, the Research Centre for Nutrigenomics and Functional Foods, Hebrew University of Jerusalem
11:30 Jul 13
A Guide to CBD, Cannabinoids and Medical Cannabis Pure CBD Vs Whole Plant Preparations
Gregor Zorn Director and Co-Founder, ECTA, European Cannabinoid Therapy Association
12:00 Jul 13
Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Concepts, Misconceptions & Evidence Medical Cannabis – From bench to bedside
Mikael Sodergren Clinical Lecturer in Surgery, Imperial College London
12:30 Jul 13
Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Concepts, Misconceptions & Evidence Haemodynamic effects of Cannabidiol in humans
Dr Saoirse O’sullivan Professor, University of Nottingham
13:00 Jul 13
Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Concepts, Misconceptions & Evidence Research on Cannabis in Cancer
Prof Dr Tamara Lah Counselor to the Director National Institute of Biology, Slovenia
13:30 Jul 13
KEYNOTE
Prof. Mike Barnes Chief Medical Officer, European Cannabis Holdings (ECH)
14:00 Jul 13
Panel Discussion Medical Cannabis Access and Patient Care
Chaired by Prof. Mike Barnes Chief Medical Officer, ECH, European Cannabis Holdings, Basia Zieniewicz Co-Founder, Families 4 Access, Hannah Deacon Patient Advocate, End Our Pain, Irit Avisar Chairperson, Israeli Medical Cannabis Nurses Association
14:45 Jul 13
Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care Awaiting Talk Title
Irit Avisar Chairperson, Israeli Medical Cannabis Nurses Association
15:15 Jul 13
Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care Novel synergistic cannabinoid combinations for the treatment of IBS and IBD patients
Zohar Koren Phd CEO, SciCann Therapeutics Inc.
15:45 Jul 13
Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care
Alex Fraser Patient Access Specialist, Grow Biotech
16:15 Jul 13
Panel Discussion Women – The Future of Cannabis
Chaired by Kristina Spionjak Marketing Director, London Canna Group, Dr Dani Gordon Doctor, Author, ABIHM, ABIOM, Dr Saoirse O’sullivan Professor, University of Nottingham, Jasmin Thomas Founder, Ohana CBD, Joanna Weaver-Pélissier CEO, BeCann
17:00 Jul 13
Celebrity Event Closing Giveaway Ignite CBD Prize Giveaways
Dan Bilzerian

Tickets